Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy
This study confirms that adult patients with MN who are ARA positive have a higher relapse rate after initial RTX treatment. Patients who are RTX-resistant and ARA positive can achieve rapid clinical remission after receiving obinutuzumab treatment.
Authors
- Yuna Chen
- Haofei Hu (ORCID: https://orcid.org/0000-0001-6061-6796)
- Shaodong Luan
- Wei Liu (ORCID: https://orcid.org/0000-0002-7905-0160)
- Rui Xue (ORCID: https://orcid.org/0000-0002-0657-4895)
- Zigan Xu
- Kang Li (ORCID: https://orcid.org/0009-0004-3816-4200)
- Biao Huang
- Ricong Xu
- Zhihang Su
- Di Wu
- Yingbo liu
- Yang Liu
- Liling Wu
- Qijun Wan
Institutions
- Zhejiang Sci-Tech University (CN)
- Longgang Central Hospital (CN)
- Changzhou Institute of Technology (CN)
- First Affiliated Hospital of Jinan University (CN)
- Shenzhen Second People's Hospital (CN)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1093/ndt/gfag054
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00